2534 related articles for article (PubMed ID: 15099365)
21. Decreased number of peripheral blood CD4 + CD29+ lymphocytes and increased in vitro spontaneous production of anti-DNA antibodies in patients with active systemic lupus erythematosus.
Gorla R; Airò P; Franceschini F; Stefani E; Braga S; Tincani A; Cattaneo R
J Rheumatol; 1990 Aug; 17(8):1048-53. PubMed ID: 1698987
[TBL] [Abstract][Full Text] [Related]
22. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
Hudnall SD; Patel J; Schwab H; Martinez J
Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
[TBL] [Abstract][Full Text] [Related]
23. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620
[TBL] [Abstract][Full Text] [Related]
24. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
Bonelli M; Savitskaya A; von Dalwigk K; Steiner CW; Aletaha D; Smolen JS; Scheinecker C
Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
[TBL] [Abstract][Full Text] [Related]
25. Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients.
Vlková M; Thon V; Sárfyová M; Bláha L; Svobodník A; Lokaj J; Litzman J
Clin Exp Immunol; 2006 Feb; 143(2):373-9. PubMed ID: 16412063
[TBL] [Abstract][Full Text] [Related]
26. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.
Scheinecker C; Zwölfer B; Köller M; Männer G; Smolen JS
Arthritis Rheum; 2001 Apr; 44(4):856-65. PubMed ID: 11315925
[TBL] [Abstract][Full Text] [Related]
27. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
[TBL] [Abstract][Full Text] [Related]
28. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus.
Hutloff A; Büchner K; Reiter K; Baelde HJ; Odendahl M; Jacobi A; Dörner T; Kroczek RA
Arthritis Rheum; 2004 Oct; 50(10):3211-20. PubMed ID: 15476242
[TBL] [Abstract][Full Text] [Related]
29. Decreased recent thymus emigrant number is associated with disease activity in systemic lupus erythematosus.
Vieira QF; Kayser C; Kallas EG; Andrade LE
J Rheumatol; 2008 Sep; 35(9):1762-7. PubMed ID: 18634155
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE
Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
[TBL] [Abstract][Full Text] [Related]
31. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets.
Ekşioglu-Demiralp E; Kibaroglu A; Direskeneli H; Yavuz S; Karsli F; Yurdakul S; Yazici H; Akoglu T
J Rheumatol; 1999 Apr; 26(4):826-32. PubMed ID: 10229403
[TBL] [Abstract][Full Text] [Related]
33. Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus.
Takasaki Y; Ogaki M; Abe K; Takeuchi K; Ando S; Tokano Y; Kobayashi S; Sekigawa I; Tsuda H; Hashimoto H
J Rheumatol; 1998 Jun; 25(6):1085-91. PubMed ID: 9632068
[TBL] [Abstract][Full Text] [Related]
34. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
[TBL] [Abstract][Full Text] [Related]
35. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
36. Urinary T cells in active lupus nephritis show an effector memory phenotype.
Dolff S; Abdulahad WH; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
Ann Rheum Dis; 2010 Nov; 69(11):2034-41. PubMed ID: 20472588
[TBL] [Abstract][Full Text] [Related]
37. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
Habib HM; Taher TE; Isenberg DA; Mageed RA
Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
[TBL] [Abstract][Full Text] [Related]
38. Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases.
Markeljević J; Batinić D; Uzarević B; Bozikov J; Cikes N; Babić-Naglić D; Horvat Z; Marusić M
J Rheumatol; 1994 Dec; 21(12):2225-30. PubMed ID: 7535356
[TBL] [Abstract][Full Text] [Related]
39. Regulatory T cells in patients with systemic lupus erythematosus.
Alvarado-Sánchez B; Hernández-Castro B; Portales-Pérez D; Baranda L; Layseca-Espinosa E; Abud-Mendoza C; Cubillas-Tejeda AC; González-Amaro R
J Autoimmun; 2006 Sep; 27(2):110-8. PubMed ID: 16890406
[TBL] [Abstract][Full Text] [Related]
40. Selective loss of the CD4+ inducers of suppressor T cell subsets (2H4+) in active systemic lupus erythematosus.
Raziuddin S; Nur MA; Alwabel AA
J Rheumatol; 1989 Oct; 16(10):1315-9. PubMed ID: 2530345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]